EudraCT Number: 2004-004148-34 Sponsor Protocol Number: B9E-XM-O435 Start Date: 2005-02-25
Sponsor Name: Dr. José Ignacio Chacón López-Muñiz
Full Title: ENSAYO EN FASE I/II DE LA COMBINACIÓN DE GEMCITABINA EN INFUSIÓN PROLONGADA Y PACLITAXEL ADMINISTRADOS DE FORMA QUINCENAL EN EL TRATAMIENTO DE PRIMERA LÍNEA DE PACIENTES CON CÁNCER DE MAMA AVANZADO
Medical condition: Cancer de mama avanzado
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-004153-25 Sponsor Protocol Number: JIA6 Start Date: 2004-12-10
Sponsor Name: Royal Hospital For Sick Children, Yorkhill Division
Full Title: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure.
Medical condition: Growth retardation secondary to juvenile idiopathic arthritis
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-004160-67 Sponsor Protocol Number: Protocol F1J-MC-SBCT (a) Start Date: 2005-02-24
Sponsor Name: Eli Lilly and Company Limited
Full Title: Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence
Medical condition: stress urinary incontinence
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: GB (Completed) DK (Completed)
Trial results: View results

EudraCT Number: 2005-005120-13 Sponsor Protocol Number: VR040/001 Start Date: 2005-12-21
Sponsor Name: Vectura Group plc
Full Title: A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patie...
Medical condition: Hypomobility (“off” or “freezing”) episodes associated with advanced Parkinson’s disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2005-005146-39 Sponsor Protocol Number: P04501 Start Date: 2006-09-14
Sponsor Name: Schering Plough Research Institute
Full Title: A Phase-2, 12-week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of a range of SCH 420814 Doses 1 mg BID, 2 mg BID, 5 mg BID and Possibly 10 mg BID in Su...
Medical condition: Moderate to severe Parkinson s disease with motor fluctuation and dyskinesias.
Disease: Version SOC Term Classification Code Term Level
8.1 10061536 Parkinson's disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results

EudraCT Number: 2007-000381-20 Sponsor Protocol Number: 27820 Start Date: 2007-11-16
Sponsor Name: Merck Serono S.A. - Geneva
Full Title: A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...
Medical condition: Relapsing Remitting Multiple Sclerosis (RRMS)
Disease: Version SOC Term Classification Code Term Level
13.1 10029205 - Nervous system disorders 10028245 Multiple sclerosis PT
Population Age: Adults Gender: Male, Female
Trial protocol: FI (Completed) FR (Ongoing) GB (Completed) CZ (Completed) BE (Completed) EE (Completed) AT (Completed) PT (Completed) NL (Completed) DE (Completed) DK (Completed) IT (Completed) GR (Completed) LV (Completed) LT (Completed) BG (Completed)
Trial results: View results
EudraCT Number: 2006-004107-20 Sponsor Protocol Number: CAS ELF Start Date: 2007-10-23
Sponsor Name: Medical University, Dpt. Internal Medicine, Div. of General Internal Medicine
Full Title: LUNG PENETRATION OF CASPOFUNGIN INTO EPITHELIAL LINING FLUID
Medical condition: Plasma and ELF concentrations of Caspofungin will be measured in patients requiring treatment with Cancidas (Caspofungin) for fungal infection (proven or suspected)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-003646-34 Sponsor Protocol Number: LT-COX-2.001 Start Date: 2005-10-10
Sponsor Name: Klaipeda hospital
Full Title: COX-2 alteration in advanced colon cancer treated with capecitabine versus 5-fluorouracil and calcium folinate (Mayo regimen) combination
Medical condition: III stage (Dukes' stage) colon cancer patients who underwent surgery
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed)
Trial results: (No results available)
EudraCT Number: 2005-003648-70 Sponsor Protocol Number: ML 19365 Start Date: 2007-02-08
Sponsor Name: Charité Universitätsmedizin Berlin
Full Title: Randomised, double-blinded phase IIIb study to optimise antiviral therapy response of a standard therapy consisting of peginterferon-alfa-2a and ribavirin plus the additional use of bezafibrat 400 ...
Medical condition: First time treatment in chronic hepatitis C-infection patients with elevated GGT-level without coinfections as HBV, HDV and HIV
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-001543-36 Sponsor Protocol Number: 091257-2005 Start Date: 2006-05-15
Sponsor Name: NHS Lothian
Full Title: The effects of lipoic acid on glycaemic control in type 2 diabetes.
Medical condition: Type 2 diabetes mellitus.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)